Last reviewed · How we verify
Glycyron (glycyrrhizic acid)
Glycyron (generic name: glycyrrhizic acid) is a glycyrrhizic acid drug. It is currently FDA-approved.
At a glance
| Generic name | glycyrrhizic acid |
|---|---|
| Drug class | glycyrrhizic acid |
| Target | High mobility group protein B1, Corticosteroid 11-beta-dehydrogenase isozyme 2, Corticosteroid 11-beta-dehydrogenase isozyme 1 |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- GU-01: Glycyrrhizin in Prostate Cancer (PHASE2)
- A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP (PHASE2)
- Revascularization of Young Immature Permenant Teeth Using Different Types of Intra Canal Medication (NA)
- F573 for Injection for the Treatment of Liver Injury/Failure (PHASE2)
- Molecular Analysis of Intracanal Microbes After Chemomechanical Procedure and Root Canal Medication: A Randomized Controlled Trial (PHASE1)
- FDGL Dose-Finding Study for Diabetic Neuropathy (PHASE2)
- A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）
- Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glycyron CI brief — competitive landscape report
- Glycyron updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Glycyron
What is Glycyron?
Glycyron (glycyrrhizic acid) is a glycyrrhizic acid drug.
What is the generic name of Glycyron?
glycyrrhizic acid is the generic (nonproprietary) name of Glycyron.
What drug class is Glycyron in?
Glycyron belongs to the glycyrrhizic acid class. See all glycyrrhizic acid drugs at /class/glycyrrhizic-acid.
What development phase is Glycyron in?
Glycyron is FDA-approved (marketed).
What does Glycyron target?
Glycyron targets High mobility group protein B1, Corticosteroid 11-beta-dehydrogenase isozyme 2, Corticosteroid 11-beta-dehydrogenase isozyme 1 and is a glycyrrhizic acid.
Related
- Drug class: All glycyrrhizic acid drugs
- Target: All drugs targeting High mobility group protein B1, Corticosteroid 11-beta-dehydrogenase isozyme 2, Corticosteroid 11-beta-dehydrogenase isozyme 1
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Metabolic
- Compare: Glycyron vs similar drugs
- Pricing: Glycyron cost, discount & access